Norgine Pharmaceuticals Limited, Pedmarqsi 80 mg/mL solution for infusion

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for Pedmarqsi 80 mg/mL solution for infusion.

Norgine Pharmaceuticals Limited is recalling specific batches due to risk of particulate matter being present in the product identified during routine stability investigations.

Pharmacists are advised to stop supplying the affected batches. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Further information, advice and details of the affected batches can be found on the MHRA website.